Receptor mechanisms mediating non-genomic actions of sex steroids
However, body weight is affected by many factors beyond peptide use
However, many doctors remain hesitant about prescribing expensive weight loss medications, and insurance battles can be frustrating and time-consuming
As GLP-1 RAs become more prevalent in treating diabetes and patients with cardiovascular disease (CVD) or risk factors for CVD, clinicians will ultimately manage the practical aspects of patient selection, dosing, special considerations, and side effects of these medications
A number of published studies have put a fluorescent tag onto GLP-1R agonists, including exendin, liraglutide, and semaglutide, and then used the fluorescent labeling to visualize the distribution of the agonist in the brain (see, e.g., Gabery et al., 2020)